{
  "schema_version": "1.0",
  "source": "medrxiv",
  "data_as_of": "2026-09-09T04:18:05.530Z",
  "selected_count": 30,
  "sampled": true,
  "records": [
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.09.03.26361736:v1",
      "title": "Optical compression of multimodal clinical data into a unified visual memory for generative trajectory forecasting",
      "summary": "Importance. Current clinical artificial intelligence is bottlenecked by highly specialized, fragmented models that reduce complex, multimodal data into isolated scalar predictions. By reframing multimodal perception as a pure vision problem, optical compression into a universal visual operating system can resolve internal data interaction bottlenecks and shift the paradigm toward continuous, generative clinical forecasting. Objective. To develop and internally validate Clinical Visual Memory, a generalist visual foundation model utilizing high-fidelity optical compression to fuse five heterogeneous intensive care unit (ICU) data modalities into a unified visual-token space, acting as a generative navigation system for critical-care trajectories. Design, Setting, and Participants. Retrospective modeling study using MIMIC-IV adult ICU encounters. After excluding stays shorter than 24 hours, 54,551 patients, 68,546 hospital admissions, and 74,829 ICU stays comprised the eligible cohort. Strict patient-level partitioning prevented cross-split leakage. Methods. Structured electronic health record (EHR) data, vital signs, 10-second electrocardiogram (ECG) waveforms, chest radiographs, and clinical notes were rendered as 2D images and encoded by a single frozen DINOv2 vision transformer. Through modality-aware latent-query cross-attention, these highly heterogeneous sources were optically compressed into a shared 1024-dimensional Clinical Visual Memory. To establish a universal output interface, this memory conditioned an conditional instruction-tuned image generator to decode eight-domain deterioration trajectories across 3- to 48-hour horizons. Visual compression fidelity was evaluated by reducing retained source-pixel area to 1%, and critical transitions were mapped using event-specific projected-axis geometry. Results. Operating as a generalist foundation, Clinical Visual Memory achieved AUROCs of 0.852 (95% CI, 0.821-0.882) for 48-hour mortality, 0.699 (0.673-0.725) for incident acute kidney injury (AKI), 0.723 (0.688-0.757) for high Sequential Organ Failure Assessment (SOFA), and 0.742 (0.726-0.757) for alive ICU discharge. Crucially, resolving the token bottleneck via an 8-fold reduction in source-pixel area preserved 98.9% of the uncompressed 48-hour mortality AUROC. Generative image-out decoding maintained clinical meaning, and trajectory geometry functioned as a proactive navigation system, yielding median warning lead times of 34.8 hours (IQR, 17.5-43.3) before death, 14.6 hours (6.5-33.2) before AKI, 15.0 hours (6.0-27.0) before high SOFA, and 20.8 hours (10.2-36.0) before recovery, with low false-alert burdens (0.040-0.109 per patient-day). Conclusions and Relevance. Clinical Visual Memory demonstrates that optical compression can successfully unify highly heterogeneous clinical data into a single, high-fidelity visual-token representation. By functioning as a continuous clinical navigation system rather than a discrete alert generator, this framework lays the architectural foundation for a generalist, generative visual operating system in critical care medicine. External and prospective validation are required before clinical deployment.",
      "published_date": "2026-09-07",
      "url": "https://doi.org/10.64898/2026.09.03.26361736",
      "metadata": {
        "doi": "10.64898/2026.09.03.26361736",
        "version": "1",
        "authors": "Guo, Z.; Jin, B.; Han, Z.; Ichikawa, T.; Ozawa, N.; Ling, X. B.",
        "category": "intensive care and critical care medicine",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_no",
        "institution": "Stanford University School of Medicine"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.09.03.26361572:v1",
      "title": "Genotype-Phenotype Correlations Reveal Positive Inheritance and Phenotype Associations for PROM1-Associated Inherited Retinal Degenerations",
      "summary": "Genetic variants in PROM1 are associated with inherited blindness, but clinical phenotypes vary widely with currently no consensus on disease expectations or predicted patient outcomes. To address this issue, we performed chi-square correlation analysis on 190 published pathogenic and likely pathogenic variants from ClinVar Miner and the Human Gene Mutation Database. We identified a statistically significant increase in observed cases of dominantly inherited missense variants, which were associated with milder forms of macular dystrophy. Recessive inheritance of truncating frameshift variants was associated with more severe forms of inherited retinal degeneration such as rod-cone dystrophy. We also present case studies from 7 patients with phenotypes that are unique, unreported, or do not match the reported phenotype in online databases. We report two patients with VUS that have clinical phenotypes and dominantly inherited missense variants, one patient with a long natural history at our clinic, two patients with the same variant, but a different clinical diagnosis, and two patients with retinal deposits comprising subretinal drusenoid deposits (SDD) and soft drusen.",
      "published_date": "2026-09-06",
      "url": "https://doi.org/10.64898/2026.09.03.26361572",
      "metadata": {
        "doi": "10.64898/2026.09.03.26361572",
        "version": "1",
        "authors": "Shoukat, M.; Papp, K. M.; Misaghi, E.; Kalra, D. J.; MacDonald, I. M.; Benson, M. D.; Carr, B. J.",
        "category": "ophthalmology",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_by_nd",
        "institution": "University of Alberta"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.09.02.26362049:v1",
      "title": "Genetic and epigenetic architecture of mass spectrometry-derived lipids in blood and their role in lifetime Major Depressive Disorder",
      "summary": "Major depressive disorder (MDD) is a highly prevalent psychiatric disorder that remains challenging to treat effectively. Difficulty predicting who will develop the disorder and which individuals will respond to treatment is most likely due to our limited mechanistic understanding and the lack of reliable biomarkers. The current literature suggests that lipid profiles differ in MDD; however, most studies do not integrate other omics layers to elucidate their potential causal relationship at the molecular level. Using phenotypic, genetic, epigenetic and mass-spectrometry lipid data from a Scottish-based cohort of approximately 1,000 participants, we examined associations with individual lipid species. We identified 77 common genetic variant associations ({beta} range = -0.46 to 0.69, p < 3.1x10-10) and 82 genome-wide DNA methylation associations ({beta} range = -1.88 to 1.39, p < 2.2x10-10). We identified 23 lipid species associated with lifetime MDD ({beta} range = -0.23 to 0.2, p < 0.05), including lipid classes such as lysophosphatidylcholine (LPC), diacylglycerol (DG) and phosphatidylcholine (PC). Our integration analysis showed that genetic variants and DNA methylation at sites annotated to the FADS gene cluster were linked with lipid species that were also associated with lifetime MDD status, including LPC(14:1) ({beta} = 0.15, p = 0.03) and PC(19:0)/(20:4) ({beta} = -0.14, p < 0.05). Our findings provide further support for the role of the FADS gene cluster in lipid metabolism and its association with MDD, while introducing DNA methylation as an additional molecular layer supporting this link.",
      "published_date": "2026-09-06",
      "url": "https://doi.org/10.64898/2026.09.02.26362049",
      "metadata": {
        "doi": "10.64898/2026.09.02.26362049",
        "version": "1",
        "authors": "Smith, H. M.; Richmond, A.; Adams, M. J.; Wretlind, A.; Marioni, R. E.; Legido-Quigley, C.; McIntosh, A. M.",
        "category": "epidemiology",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_by",
        "institution": "Institute of Neuroscience and Cardiovascular Research, University of Edinburgh, Edinburgh, UK"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.09.02.26362047:v1",
      "title": "ULTRASOUND OF QUADRICEPS FEMORIS AS A RULE-OUT TOOL FOR MALNUTRITION SCREENING IN HEART FAILURE CLINICS",
      "summary": "Aims: To assess the reproducibility and repeatability of quadriceps femoris muscle (QFM) thickness measured by 2D ultrasound (US) and evaluate its potential as a tool to detect the risk of malnutrition in heart failure (HF) outpatients. Methods: Thirty HF participants (malnourished n=16; well-nourished n=14) were recruited. Malnutrition was assessed using the GLIM tool (reference method). QFM thickness was measured at two points (mid-point and 2/3-point). We conducted paired T-tests to assess differences in QFM thickness according to leg side (left vs. right), condition of measurement (with vs. without probe pressure), and inter- and intra-operator. Intraclass correlation coefficients (ICC) were used to test intra- and inter-operator agreement. Results: Analyses showed no differences for most comparisons (total of 48). The midpoint was different in 4 comparisons; 2/3 point for none. ICC analyses ranged from 0.943 to 0.996 for intra- and inter-operator analyses. The best result from the ROC analyses was for the 2/3 QFM point with no probe pressure (AUC 0.74), with a specificity of 43% and sensitivity of 100%. Conclusion: Our preliminary results suggest that 2D US QFM thickness, measured at the two-thirds point without pressure, is a reproducible and repeatable measurement. QFM thickness also showed good ability to differentiate between nutritional statuses and to rule out malnutrition (high sensitivity). These findings indicate it as a practical initial screening tool for identifying patients who do not need further investigation. However, these preliminary findings need to be confirmed in a larger sample of patients.",
      "published_date": "2026-09-06",
      "url": "https://doi.org/10.64898/2026.09.02.26362047",
      "metadata": {
        "doi": "10.64898/2026.09.02.26362047",
        "version": "1",
        "authors": "A B Ribeiro, P.; Zuchinalli, P.; Carrier, Z.; Nguyen, O.; Zenses, A.-S.; Corra Souza, G.; Tournoux, F.",
        "category": "cardiovascular medicine",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_by_nc_nd",
        "institution": "Acoeurlab Research Unit - Research Center of the Hospital of Montreal University (CRCHUM), Montreal, Quebec, Canada. Acoeurlab Research Unit; Research Institute"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.09.02.26362046:v1",
      "title": "Paediatric escalation area and corridor care in the Emergency Department, a secondary analysis of the UNCORKED study",
      "summary": "Objective: To describe the use of, and outcomes following, Emergency Department (ED) escalation area care among children. Design: Two-stage prospective multicentre observational study. Stage one was a cross-sectional snapshot study reporting the point prevalence of escalation area care; stage two was an observational cohort study of eligible participants present in the EDs during snapshots. Setting: 5 snapshots of 96 type 1 UK EDs. 83/96 (86.5%) of sites were mixed EDs and 13 sites were paediatric-only EDs. Patients: Patient level data was collected on those who experienced escalation area care and/or were admitted. Outcomes: The primary outcome was the proportion of patients cared for in escalation areas in paediatric-only EDs. Secondary outcomes were demographics, length of stay (LOS), 28-day mortality, type of escalation area experienced and time in escalation areas in all ED types; stratified by escalation area experience. Results: 6.6% (n=75/1132) of patients in paediatric-only EDs were receiving escalation area care during the study snapshots, the majority of this occurred in a minority of departments. Across all ED types, 15.4% (n=104/675) of admitted children experienced escalation area care during their ED stay. 124/244 (50.8%) of those cared for in escalation areas were cared for in a non-clinical area such as a corridor. 9.6% (n=8/83) of mixed EDs reported caring for adults in paediatric areas. Three children died within 28 days; all admitted to hospital without experiencing escalation area care. Hospital LOS was 2.00 days (1.00, 3.00) for those in escalation areas and 2.00 days (2.00, 4.00) for those not cared for in escalation areas. Conclusions: Escalation area care is a common and systemic feature of paediatric emergency care in the UK which requires urgent action to ensure children are cared for in appropriate environments.",
      "published_date": "2026-09-06",
      "url": "https://doi.org/10.64898/2026.09.02.26362046",
      "metadata": {
        "doi": "10.64898/2026.09.02.26362046",
        "version": "1",
        "authors": "Anakebe, C.; Owens, D. R.; Roland, D. R.; Birse, F.; McHenry, R. D.; Clarke, B.; Roberts, T.; Trainee Emergency Research Network UNCORKED study group,  ",
        "category": "emergency medicine",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_by",
        "institution": "Bristol Medical School, University of Bristol, UK"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.09.02.26362042:v1",
      "title": "The impact of extranodal spread on overall and recurrence-free survival in patients with clinically early-stage cervical cancer, but with tumor positive pelvic lymph nodes after radical hysterectomy",
      "summary": "Objective Extranodal spread is an adverse prognostic factor in several cancers. In clinically early-stage cervical cancer and positive lymph nodes after radical hysterectomy, extranodal spread is routinely registered in pathology reports, but it does not influence adjuvant treatment decisions. This nationwide study assessed the prognostic value of extranodal spread. Methods Patients diagnosed between 2009 and 2024 with clinical early-stage cervical cancer (TNM T1 to T2a2) and pathologically positive regional lymph nodes after radical hysterectomy were identified from the Netherlands Cancer Registry. Cox proportional-hazard models assessed differences in overall survival and recurrence-free survival. A Bayesian Cox model with informative prior was applied to complement overall survival analysis. Recurrence patterns were compared by extranodal spread status. Results Among 408 patients, 46 (11.3%) had extranodal spread. In multivariable frequentist analysis, extranodal spread was significantly associated with poorer recurrence-free survival (hazard ratio [HR] 1.97, 95% confidence interval [CI] 1.11-3.49), but not with overall survival (HR 1.37, CI 0.78-2.41). Bayesian analysis showed a significant difference in overall survival (HR 1.63, CI 1.14-2.27). Among patients with recurrence, the distribution of locoregional and distant recurrence patterns did not significantly differ between those with and without extranodal spread (p=0.09). Conclusion Extranodal spread is associated with poorer recurrence-free survival in clinically early-stage cervical cancer treated with radical hysterectomy. For overall survival, results were directionally consistent but dependent on the analytical approach, likely reflecting limited statistical power. These findings suggest a role for extranodal spread in risk stratification and follow-up, warranting further investigation before informing treatment decisions.",
      "published_date": "2026-09-06",
      "url": "https://doi.org/10.64898/2026.09.02.26362042",
      "metadata": {
        "doi": "10.64898/2026.09.02.26362042",
        "version": "1",
        "authors": "van der Ven, R. G. F. M.; Wenzel, H. H.; van der Aa, M. A.; Mom, C. H.; Thuijs, N. B.; van der Velden, J.",
        "category": "oncology",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_by_nc_nd",
        "institution": "Netherlands Comprehensive Cancer Organisation"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.09.02.26362037:v1",
      "title": "Performance of protein panels is inflated across many biomarker studies",
      "summary": "Data leakage is a prevalent yet underappreciated flaw in biomarker discovery studies. Through simulation and real-world proteomic data, we demonstrate that typical pipelines are broadly susceptible to this issue, producing inflated performance estimates, poor generalization, and excess false positives. We further introduce two tools to detect data leakage at the code and manuscript level, providing a practical path toward more rigorous and reproducible biomarker reporting.",
      "published_date": "2026-09-06",
      "url": "https://doi.org/10.64898/2026.09.02.26362037",
      "metadata": {
        "doi": "10.64898/2026.09.02.26362037",
        "version": "1",
        "authors": "An, L.; Finney, C. A.; Shvetcov, A.; The Global Neurodegeneration Proteomics Consortium,  ; Vogel, J.",
        "category": "neurology",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_by_nc_nd",
        "institution": "Lund University"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.09.02.26361977:v1",
      "title": "A dual proteomics analysis of paired cerebrospinal fluid and plasma from patients with neurodegenerative diseases",
      "summary": "INTRODUCTION: Understanding concordance across biofluids and platforms is critical for understanding neurodegenerative biomarkers results and translating them into clinical use; yet systematic comparisons remain limited. To address this gap, we performed large-scale proteomic profiling of patient-paired plasma and CSF to characterize cross-modal relationships. METHODS: We profiled paired plasma and CSF from 67 individuals using SomaScan 11K and NULISAseq CNS panels. Disease severity was assessed with the CDR+NACC FTLD-M Global Score. RESULTS: We identified 269 SomaScan and 18 NULISA proteins with significant cross-biofluid correlation. Cross-platform concordance within biofluids was strong. NEFL, NPTX2, TREM2, and CHIT1 demonstrated consistent cross-platform agreement. Associations with disease severity were compartment-specific, with decreased NPTX2 in CSF, increased NEFL and GFAP in plasma, and decreased TREM2 across biofluids. DISCUSSION: Cross-platform consistency supports biomarker robustness, while limited cross-biofluid concordance highlights compartmental biology. Given additional clinical correlations despite varying underlying pathology, these findings may point to shared neurodegenerative disorder pathways.",
      "published_date": "2026-09-06",
      "url": "https://doi.org/10.64898/2026.09.02.26361977",
      "metadata": {
        "doi": "10.64898/2026.09.02.26361977",
        "version": "1",
        "authors": "Kowal, I.; Scholz, S. W.; Epstein, J.; Traynor, B. J.; Danielian, L. E.; Hao, Y.; Crook, J.; Li, Z.; Porter, K.; Sellers, B.; Langowski, T. J.; Denkinger, M. N.; Ashton, N. J.; Van Keuron-Jensen, K.; Cookson, M. R.; Kwan, J. Y.; Qi, Y. A. A.; Snyder, A.",
        "category": "neurology",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc0",
        "institution": "Center for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institute"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.09.02.26361948:v1",
      "title": "Surgical Critical Care Outcomes Before and After the Onset of the COVID-19 Pandemic: A Single-Center Retrospective Comparative Audit",
      "summary": "This audit aimed to determine whether the pattern of presenting abdominal pathology, procedures performed, and clinical outcomes in our surgical intensive care unit (SICU) changed during the COVID-19 period. We reviewed a total of 356 patients who were admitted to the SICU with 1st March 2020 taken as the reference cutoff date. Two hundred and five (57.6%) cases occurred in the Pre-COVID interval and 151 (42.4%) in the Post-COVID interval. Patients admitted to SICU Post-COVID were significantly older than those admitted Pre-COVID (54.2 vs. 48.3 years, p = 0.005). Hospital and SICU length of stay were unchanged across the pandemic (p = 0.824 and 0.601 respectively). The procedure case-mix shifted significantly (p = 0.014): appendectomy, gastrectomy/sleeve gastrectomy and thoracic procedures fell, while exploratory laparotomy rose, consistent with reduced elective/minimally-invasive activity and a shift toward emergency open surgery. Appendiceal disease was recorded significantly less often as the presenting diagnosis Post-COVID (p = 0.016), and intestinal obstruction showed a non-significant upward trend (p = 0.071). SICU mortality and overall admission outcome were unchanged across the pandemic (p = 1.000 and 0.664).",
      "published_date": "2026-09-06",
      "url": "https://doi.org/10.64898/2026.09.02.26361948",
      "metadata": {
        "doi": "10.64898/2026.09.02.26361948",
        "version": "1",
        "authors": "Ali, S. M. H.; Yasin, U.; Ather, O.; Malik, A.",
        "category": "surgery",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_by",
        "institution": "FMH College of Medicine & Dentistry"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.09.02.26361916:v1",
      "title": "Autograft Selection in Anterior Cruciate Ligament Reconstruction: A Meta-Analysis of Patellar Tendon versus Hamstring Tendon Outcomes in Randomized Controlled Trials",
      "summary": "Abstract Introduction The optimal autograft choice for anterior cruciate ligament (ACL) reconstruction remains a subject of debate in orthopedic surgery. This meta-analysis evaluates long-term structural outcomes and donor-site complications by pooling data exclusively from high-quality randomized controlled trials (RCTs) directly comparing patellar tendon (PT) and hamstring tendon (HT) autografts. Methods A systematic literature search was conducted to identify randomized clinical trials comparing primary PT and HT autografts. Revision surgeries and allografts were excluded. The primary endpoints analyzed were graft failure, objective rotational stability, and post-operative anterior knee pain (AKP). Results Data were pooled from 5 core RCTs encompassing 713 patients. A random-effects meta-analysis showed that the trend toward lower structural graft failure with PT autografts did not reach statistical significance [RR = 1.55, 95% CI: 0.82 to 2.93, $p = 0.174$]. However, PT autografts demonstrated statistically superior objective knee rotational stability [RR = 0.89, 95% CI: 0.84 to 0.95, $p < 0.001$]. Conversely, HT autografts were associated with a significant reduction in donor-site morbidity, demonstrating a 63% relative reduction in chronic post-operative anterior knee pain [RR = 0.37, 95% CI: 0.28 to 0.49, $p < 0.001$]. Conclusions Patellar tendon autografts provide superior objective rotational stability, though the observed reduction in structural graft failure rates was not statistically significant. Hamstring tendon autografts significantly reduce post-operative donor-site morbidity and chronic kneeling pain. Graft selection should be tailored to patient-specific athletic demands and occupational requirements. Clinical consensus regarding the optimal autograft selection for primary anterior cruciate ligament (ACL) reconstruction remains divided. While bone-patellar tendon-bone (PT) autografts have historically been associated with excellent mechanical stability, quadrupled hamstring tendon (HT) autografts are widely utilized to mitigate donor-site morbidity. However, individual randomized controlled trials often present variable data regarding the precise magnitude of differences in rotational laxity and long-term anterior knee pain. This meta-analysis pools recent high-quality prospective randomized controlled trials to provide a precise, consolidated quantitative matrix of clinical outcomes. It confirms that while the PT configuration offers statistically superior objective rotational joint stability (p < 0.001), the HT configuration yields a profound 63% relative risk reduction (p < 0.001) in chronic post-operative anterior knee pain and kneeling distress. This defines a clear trade-off matrix to guide patient-specific graft selection based on occupational and physical demands.",
      "published_date": "2026-09-06",
      "url": "https://doi.org/10.64898/2026.09.02.26361916",
      "metadata": {
        "doi": "10.64898/2026.09.02.26361916",
        "version": "1",
        "authors": "Akram, S.; Nadeem, M.",
        "category": "orthopedics",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_no",
        "institution": "Shahida Islam medical college"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.09.02.26361780:v1",
      "title": "MAP3K7 Loss of Function Causes Dilated Cardiomyopathy",
      "summary": "Background and Aims: Dilated cardiomyopathy (DCM) is a genetically heterogeneous cause of heart failure and sudden cardiac death. Many patients remain without a molecular diagnosis. MAP3K7 encodes TAK1, a serine/threonine kinase important for cardiac homeostasis. MAP3K7 variants are an established cause of syndromic disease, including cardiospondylocarpofacial syndrome (CSCF), in which DCM has been occasionally reported. Here, we demonstrate that MAP3K7 variants can cause apparently isolated DCM, expanding the phenotypic spectrum of MAP3K7-related disorders. Methods: We compiled four orthogonal lines of human genetic evidence: de novo variation in paediatric cardiomyopathy; common variant association with adult DCM; familial segregation; and rare variant enrichment in DCM cases, together with functional categorisation of rare variants. Results: In 117 paediatric cardiomyopathy trios from the 100,000 Genomes Project, two probands harboured rare de novo MAP3K7 missense variants, significantly more than expected (Bonferroni-adjusted p=0.036). Independent GWAS implicated MAP3K7 as a susceptibility locus for adult DCM. Across global DCM cohorts, we identified families harbouring rare MAP3K7 variants, including one with segregation in nine affected relatives. Rare damaging non-truncating variants were enriched in DCM cases, while truncating variants were associated with DCM in the Genomics England cohort and increased left ventricular volumes in UK Biobank. DCM-associated variants reduced TAK1 kinase activity, supporting a loss-of-function mechanism consistent with CSCF-associated alleles. Conclusion: Multiple independent lines of evidence establish an association between MAP3K7 loss of function variants and DCM. Several affected individuals lacked overt syndromic features, demonstrating that MAP3K7-related disease may present as apparently isolated DCM across the lifespan and supporting inclusion of MAP3K7 in DCM diagnostic pipelines.",
      "published_date": "2026-09-06",
      "url": "https://doi.org/10.64898/2026.09.02.26361780",
      "metadata": {
        "doi": "10.64898/2026.09.02.26361780",
        "version": "1",
        "authors": "Josephs, K. S.; Smith-Diaz, C. C.; Woods, A.; Prince, C.; Zheng, S. L.; Buchan, R.; Cavanagh, E.; Elahi, S.; Jennings, E.; Procter, H.; McTaggart, J. S.; Janan, R.; Theotokis, P.; Baker, A.; Henden, N.; McGurk, K. A.; Prescott, K.; Newcastle Clinical Genetics Team,  ; Jobanputra, V.; James, P.; Thompson, T.; Zentner, D.; Tayal, U.; Halliday, B. P.; Prasad, S. K.; O'Regan, D. P.; Lumbers, R. T.; Barton, P. J. R.; Richardson, K.; Klaassen, S.; Rico-Armada, A.; Daubeney, P. E. F.; Hartill, V. L.; Page, S. P.; Roberts, A. M.; Carling, D.; Ingles, J.; Ware, J. S.; GoDCM Consortium,  ",
        "category": "genetic and genomic medicine",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_by",
        "institution": "Garvan Institute of Medical Research and University of New South Wales, Sydney, NSW, Australia; School of Clinical Medicine, Faculty of Medicine and Health, Uni"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.09.02.26361744:v1",
      "title": "Adolescent Voices on Global Racisms: Lived Experiences, Health Impacts and Demands Across Six Countries",
      "summary": "Introduction: Although the mechanisms of racism may be globally consistent, both these mechanisms and their context-specific expressions require further investigation. Comparing perceptions and experiences of minoritised adolescents across countries helps reveal how racism manifests in different contexts. This multi-country study investigates how adolescents understand, experience, and demand action against the racisms that shape their health and lives. Methods: We conducted semi-structured interviews with 93 adolescents from minoritised groups across Brazil, Peru, South Korea, Sri Lanka, Uganda, and the UK, using culturally adapted vignettes. Using inductive thematic analysis, country-based and external coders applied a co-developed cross-country codebook, achieving high inter-rater reliability, and identified seven key themes. Results: Participants' narratives showed how appearance, language, and socioeconomic status functioned as social markers through which racism reproduced inequities in education, healthcare, and economic opportunity. Across contexts, racism imposed psychological strain, through social exclusion combined with pressure to succeed. This affected adolescent health, contributing to emotional distress, low self-esteem, and uncertainty, while shaping help-seeking, institutional trust, and exposure to material conditions that worsened physical health. Experiences varied: ethnic diversity in the UK offered perceived protection from interpersonal discrimination; economic security in South Korea helped render a minoritised identity an asset; while spatial segregation in Brazil, Peru, Sri Lanka, and Uganda reduced external threat but intensified structural disadvantage. Adolescents called for stronger support networks, anti-racist education, accountability, improved opportunities, and broader justice in workplaces and online spaces. Conclusion: Our findings underscore that addressing racism's impacts on adolescent health requires a health justice approach. This must recognise racism as a public health crisis, confront racialised structural inequities, promote resource access, and engage adolescents in policy development.",
      "published_date": "2026-09-06",
      "url": "https://doi.org/10.64898/2026.09.02.26361744",
      "metadata": {
        "doi": "10.64898/2026.09.02.26361744",
        "version": "1",
        "authors": "Sato, P. d. M.; English, S.; Mannell, J.; Ni Chobhthaigh, S.; Choi, H.; Calderon, M.; Nagginda, H. P.; Mulindwa, P. H.; Weerasekara, A.; Kim, S.-S.; Wettasinghe, K.; Galappatti, A.; Li, R.; Huq, M.; Binboga, Z.; Parker, C.; Devakumar, D.",
        "category": "public and global health",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_by",
        "institution": "Federal University of Bahia"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.09.02.26361635:v1",
      "title": "Fear of Dementia among Middle-Aged and Older Adults in China: Lived Experiences, Coping, and Support Needs",
      "summary": "Background: Fear of dementia (FoD) can shape psychological well-being and responses to perceived cognitive change. Qualitative research has begun to show that dementia-related fear extends beyond memory loss to anticipated threats to independence, identity, and control. Less is known about how people manage these concerns in everyday life, what support they consider meaningful, and how these experiences unfold across sociocultural contexts. This study explored lived experiences of FoD, coping responses, and support needs among middle-aged and older adults in China. Methods: In-depth semi-structured interviews were conducted on adults aged 45 years and older with some concern about developing dementia. A fictional third-person vignette facilitated discussion of this potentially sensitive topic. Data were analyzed using Framework Analysis, with Theoretical Domains Framework domains providing a deductive higher-level structure and more specific subthemes developed through iterative, data-driven comparison within and across cases. Results: Twenty participants described fear of dementia as a socially embedded and future-oriented experience shaped by dementia-related knowledge, exposure, family roles, and concerns about autonomy, dignity, and burdening others. Coping strategies ranged from proactive self-management to avoidance and distraction, often supported by family members or peers. Participants consistently expressed a need for practical information, reassurance, and actionable strategies to maintain cognitive health. Preferred interventions were accessible, low-burden, and professionally guided. Although digital delivery was generally viewed as acceptable, engagement was perceived to depend on usability, trust, and digital literacy. Discussion and Implications: Findings extend prior qualitative work on dementia-related anxiety by showing how fear is managed through both agency and avoidance and how support needs are embedded in relational and sociocultural contexts. Interventions addressing fear of dementia may benefit from being culturally sensitive, accessible, and responsive to users' lived experiences. Attention to co-creation, participatory approaches, and equity may help support engagement and promote psychological well-being in ageing societies.",
      "published_date": "2026-09-06",
      "url": "https://doi.org/10.64898/2026.09.02.26361635",
      "metadata": {
        "doi": "10.64898/2026.09.02.26361635",
        "version": "1",
        "authors": "Dai, H.; Versluis, A.; Xu, R.; Achterberg, W.; Shen, H.; Chavannes, N.; Aardoom, J.",
        "category": "public and global health",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_by_nc_nd",
        "institution": "Leiden University Medical Center"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.09.02.26361584:v1",
      "title": "Improving rational medicine prescribing at a public district hospital in southwestern Uganda, January-November 2021: a quality improvement initiative",
      "summary": "Irrational prescribing can compromise patient safety, medicine availability, and antimicrobial stewardship. At a public district hospital in southwestern Uganda, a 2019 internal audit prompted by recurrent stock-outs found approximately three medicines per outpatient prescription, four per inpatient prescription, and antibiotics in about 60% of outpatient prescriptions. We implemented a six-month quality improvement initiative to increase prescribing concordant with the Uganda Clinical Guidelines (UCG) and improve key indicators of rational medicine use among outpatients. From January to November 2021, we conducted an uncontrolled before-and-after quality improvement evaluation. Prescription records were selected by systematic random sampling at baseline and six-month endline. We reviewed 350 baseline and 101 endline outpatient prescriptions. The primary outcome was prescription concordance with UCG. Secondary outcomes included antibiotic prescribing, number of medicines per encounter, generic prescribing, and injection use. Adjusted analyses accounted for age, sex, and diagnostic group. Following root-cause analysis, the hospital quality improvement (QI) team implemented prescriber education, provided clinicians with soft-copy PDF versions of the UCG and essential medicines lists, restricted prescribing to recognized clinicians with signature verification, and instituted periodic prescription audit and feedback. Guideline-concordant prescribing increased from 43.7% to 76.2% (adjusted change, +32.8 percentage points; 95% CI, 21.9-43.8; aPR=1.82; 95% CI, 1.51-2.20). Antibiotic prescribing decreased from 83.4% to 65.3% (adjusted change, -17.9 points; 95% CI, -27.8 to -8.0; aPR=0.80; 95% CI, 0.70-0.91). Mean medicines per encounter decreased from 3.35 to 2.66 (adjusted mean difference, -0.61; 95% CI, -0.79 to -0.43), while prescriptions containing only generic medicines increased from 78.6% to 94.1% (adjusted change, +13.6 points; 95% CI, 5.8-21.4). Guideline-concordant prescribing increased, while antibiotic use and medicine burden declined and generic prescribing improved. Antibiotic use nevertheless remained high, underscoring the need for continued stewardship, audit, and iterative QI.",
      "published_date": "2026-09-06",
      "url": "https://doi.org/10.64898/2026.09.02.26361584",
      "metadata": {
        "doi": "10.64898/2026.09.02.26361584",
        "version": "1",
        "authors": "Migisha, R.; Namasambi, S.; Kwesiga, B.; Bulage, L.; Ario, A. R.",
        "category": "public and global health",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_by",
        "institution": "Uganda National Institute of Public Health"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.09.02.26361557:v1",
      "title": "Peer Facilitation as a Methodological Condition: What Participatory Photovoice Revealed About Transition to Adulthood Among Youth Living with HIV in India",
      "summary": "Transition readiness instruments for youth living with HIV were developed in high-income settings and define readiness as clinical competence and individual autonomy. Few reflect youth in low- and middle-income settings, where family obligation and community stigma shape the passage to adulthood. In March 2026, sixteen youth living with HIV aged 13-22 years took part in a peer-facilitated photovoice study at two sites in Karnataka, India: Bengaluru and Belgaum. Participants photographed and collectively interpreted their experiences of growing up and their expectations of the future. Six returned in May 2026 for a reflective discussion of the method. Participants defined independence as the capacity to sustain others, located the principal risks of transition in relational and social rather than clinical domains, and recommended that transition preparation begin around age twelve. Reciprocal obligation was absent from the initial codebook and emerged through participants' visual metaphors. Peer facilitation was a condition of the inquiry rather than an enhancement of it, and photovoice reporting should specify who exercised interpretive authority. Participatory photovoice can broaden prevailing definitions of transition readiness and inform more youth-responsive assessments.",
      "published_date": "2026-09-06",
      "url": "https://doi.org/10.64898/2026.09.02.26361557",
      "metadata": {
        "doi": "10.64898/2026.09.02.26361557",
        "version": "1",
        "authors": "Sulladmath, A.; Sannigrahi, S.; Reddy, S.; Gowda, M.; Raj, M. B.; Kumar SK, S.; Ganapathi, L.; Shet, A.",
        "category": "public and global health",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_by_nc",
        "institution": "John Hopkins University"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.09.02.26361445:v1",
      "title": "A Valid and Reliable Virtual Reality Tool for Assessment of Arm Nonuse Post-Stroke",
      "summary": "Introduction: Approximately 40-80% of individuals post-stroke fail to use their paretic arm despite sufficient capacity, a phenomenon known as arm nonuse. This behavior arises from an interaction between cognitive and motor factors, necessitating evaluation approaches that capture the impact of complex task demands on arm nonuse. However, existing measures require specialized equipment, extensive setup, or prolonged monitoring, limiting their clinical feasibility. To address this gap, this study evaluated the reliability, validity, and usability of a novel virtual reality-based arm nonuse (VR-NonUse) tool designed to measure arm nonuse during naturalistic reaching under varying cognitive and motor demands. Methods: Fifty-one individuals with stroke and 23 controls completed the VR-NonUse assessment across three conditions varying in cognitive and motor demand. Usability and tolerability were evaluated. Concurrent validity was examined by assessing associations between paretic arm nonuse on the VR-NonUse tool and established nonuse assessments. Discriminant validity was evaluated by comparing these associations with a motor impairment measure. Construct validity was examined by determining the effects of cognitive and motor demand on arm use. Results: The VR-NonUse tool was usable and well-tolerated. Paretic arm nonuse on the VR-NonUse tool was associated with established nonuse measures, and more strongly related to nonuse than to motor impairment, supporting concurrent and discriminant validity. Higher cognitive demand reduced paretic arm use, supporting construct validity. A brief cognitively demanding condition yielded a robust index of nonuse. Discussion: The VR-NonUse tool is a reliable, valid, and practical assessment of arm nonuse in chronic stroke.",
      "published_date": "2026-09-06",
      "url": "https://doi.org/10.64898/2026.09.02.26361445",
      "metadata": {
        "doi": "10.64898/2026.09.02.26361445",
        "version": "1",
        "authors": "Gangwani, R.; Zodrow, S.; DeAngelis, A.; Karrenbach, M.; Kantak, S.; Buxbaum, L. J.",
        "category": "rehabilitation medicine and physical therapy",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_no",
        "institution": "Jefferson Moss Rehabilitation Research Institute, Thomas Jefferson University, Elkins Park, PA"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.09.02.26361107:v1",
      "title": "Adaptation needs of an intervention to facilitate tobacco cessation among men attending emergency departments in Nairobi, Kenya",
      "summary": "Background: Three-quarters of cancer deaths globally are in low- or middle-income countries. Cost-effective tobacco cessation interventions are critical to reducing cancer burden in these settings. Interventions that reach men, who are more likely to smoke and less likely to be engaged in primary care, are particularly important in Kenya, where 84% of smokers are men. Engaging men using a text-based mHealth program is a promising strategy to promote cessation. Text-based quit counseling using Text2Quit, a US-based mHealth intervention, has been demonstrated to be effective in high-income settings. We aimed to identify barriers to using Text2Quit among Kenyan men who smoke and optimize Text2Quit for Kenya. Methods: We invited men who smoke in Nairobi, Kenya to participate in intercept interviews using a Text2Quit prototype adapted for Kenya. A multinational team of tobacco experts, designers, Kenyan physicians, and implementation researchers carried out a rapid analysis of interview transcripts to identify barriers to its usability, relatability, and appeal. These barriers and proposed solutions were enumerated and ranked using nominal group technique with rank-order voting. Results: Thirteen men participated in interviews using a Text2Quit-Kenya prototype. Participants identified rigid response formats as a barrier to its usability, long text messages as a barrier to relatability, and confusion about cost as a barrier to its appeal. Twenty-six proposed solutions were identified by the nominal group technique process and five were prioritized based on importance to stakeholders and feasibility: 1) enable minor deviations in patient responses, 2) reduce length of messages, 3) clearly communicate that Text2Quit is free of charge, 4) provide brief in-person counseling at enrollment, including training on how to find and reply to texts and setting a quit date before texts begin, and 5) provide individualized follow up with users. Conclusions: Barriers to uptake of Text2Quit among Kenyan men who smoke are addressable through a systematic adaptation process.",
      "published_date": "2026-09-06",
      "url": "https://doi.org/10.64898/2026.09.02.26361107",
      "metadata": {
        "doi": "10.64898/2026.09.02.26361107",
        "version": "1",
        "authors": "Armstrong-Hough, M.; Kedera, T.; Bosire, M.; Obuya, M.; Soma, G.; Rayo, J.; Abroms, L.; Ngaruiya, C.",
        "category": "public and global health",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_by",
        "institution": "NYU School of Global Public Health"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.09.02.26361014:v1",
      "title": "Artificial Intelligence and Mobile Health Technologies for Improved Healthcare Access: Design and Pilot Evaluation of an Integrated Digital Health Platform for a Nigerian Teaching Hospital",
      "summary": "Healthcare access barriers among Nigerian university students remain under-researched, particularly regarding localized digital health interventions. This study designed, developed, and evaluated a mobile health platform integrating AI-assisted triage, teleconsultation, appointment scheduling, and records management for students at the University of Abuja Teaching Hospital (UATH). A single-group pre-post design was conducted with 50 enrolled student-patients, with each participant observed for 30 days. The platform's triage feature utilized MedGemma, deployed locally via Ollama on UATH infrastructure using a multi-turn conversational architecture. Evaluation metrics included a survey operationalizing the Penchansky and Thomas access framework, the System Usability Scale (SUS), and triage validation against two independent clinicians using weighted Cohen's kappa. Among 61 in-scope triage sessions from 28 participants, mean triage response time was 34.8 seconds with no performance degradation. Among 22 participants completing the SUS, the mean score was 73.2, significantly exceeding the standard 68 benchmark (p = .046). Healthcare access improved directionally across four of five measured dimensions. AI triage classifications demonstrated substantial agreement with independent clinicians (kappa = 0.66-0.72), strengthening in longer conversations. No significant access equity differences were detected between on-campus and off-campus participants in the underpowered pilot subgroup analysis. This study demonstrates the technical feasibility, usability, and clinical concordance of a locally deployed, AI-assisted health platform in a resource-constrained Nigerian setting, providing, to our knowledge, the first evaluation of MedGemma for AI-assisted triage among Nigerian university students and justifying a larger, fully powered follow-up study.",
      "published_date": "2026-09-06",
      "url": "https://doi.org/10.64898/2026.09.02.26361014",
      "metadata": {
        "doi": "10.64898/2026.09.02.26361014",
        "version": "1",
        "authors": "Ochem, O. E.; Ezego, O. P.",
        "category": "health systems and quality improvement",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_by",
        "institution": "University of Abuja"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.09.01.26361911:v1",
      "title": "Socioeconomic inequalities in cannabis use among European adolescents: the role of access and risk perception",
      "summary": "Introduction There is evidence that regular and high-risk-consumption is more prevalent among adolescents with a lower socioeconomic family status (SES). Yet, the causes for the SES gap remain unclear. We postulate that SES inequalities in regular and high-risk cannabis use among adolescents are mediated by differences in risk perception and access. Methods This cross-sectional study used data from a survey to students aged 15-17 years from 35 European countries in 2019 (European School Survey Project on Alcohol and Drugs). We modelled current regular use ([&ge;]10 times in the past month) and past-year high-risk/problematic use as a function of maternal and paternal education, adjusting for age, sex, and country, then further adjusting for moderating variables: perceived cannabis availability and perceived risk of harm. Results Lower paternal education was related to both higher regular and high-risk use (OR: 1.55 (1.20-2.0) and OR: 1.77 (1.49-2.11), respectively. A similar pattern was observed with maternal educational level. Including mediating factors, perceived availability increased the likelihood of higher use among adolescents with lower SES, related to their lower perceived availability. In contrast, adjusting for risk perception, SES factors lost significance for regular use and reduced OR by 40 to 50% for high-risk use. Conclusion Results indicate that SES inequalities in perceived risk explain the SES gap in regular and high-risk cannabis use among the worse-off. Attention should be paid to policies that may foster the perception that cannabis is risky, which may aggravate dangerous consumption among the worse-off, contributing to larger SES inequalities.",
      "published_date": "2026-09-06",
      "url": "https://doi.org/10.64898/2026.09.01.26361911",
      "metadata": {
        "doi": "10.64898/2026.09.01.26361911",
        "version": "1",
        "authors": "Perelman, J.; Cardoso, M.; Alves, J.; Palladino, C.",
        "category": "public and global health",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_by_nc_nd",
        "institution": "NOVA National School of Public Health, Public Health Research Centre, Comprehensive Health Research Center, CHRC, NOVA University Lisbon"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.09.01.26361892:v1",
      "title": "Baseline intratumoral TCRbeta; and TCRgamma; repertoires predict response to immune checkpoint inhibitors in advanced renal cell carcinoma",
      "summary": "Immune checkpoint inhibitors (ICIs) have transformed the treatment landscape of advanced renal cell carcinoma (RCC), yet only a subset of patients derives durable clinical benefit and no robust predictive biomarkers have been implemented in routine clinical practice. As T-cell receptor (TCR)-mediated antigen recognition underlies effective antitumor immunity, characterization of the intratumoral TCR repertoire may provide clinically relevant information for patient stratification. Here, we evaluated the predictive value of the baseline intratumoral TCR{beta} and TCR{gamma} repertoires in a real-world cohort of patients with advanced RCC treated predominantly with first-line immune checkpoint inhibitor-based regimens. Responders exhibited a significantly more even TCR{beta} repertoire together with increased TCR{gamma} diversity and clonal richness, whereas non-responders showed greater TCR{gamma} clonal dominance. In addition, the preferential usage of specific TRBV genes, including TRBV5.7, TRBV7.1, and TRBV18, was associated with clinical response and longer progression-free survival. In this exploratory cohort, integration of the most informative TCR{beta} and TCR{gamma} variables into a combined random forest model yielded an area under the receiver operating characteristic curve of 0.90 in leave-one-out cross-validation, with 100% sensitivity and 81.8% specificity at the selected threshold. To our knowledge, this is the first study to simultaneously characterize baseline intratumoral TCR{beta} and TCR{gamma} repertoires in patients with advanced RCC predominantly receiving first-line immune checkpoint blockade. These findings support baseline intratumoral TCR repertoire features as candidate tissue biomarkers for pretreatment patient stratification and provide a rationale for the prospective validation of TCR repertoire profiling as a predictor of immunotherapy benefit in RCC.",
      "published_date": "2026-09-06",
      "url": "https://doi.org/10.64898/2026.09.01.26361892",
      "metadata": {
        "doi": "10.64898/2026.09.01.26361892",
        "version": "1",
        "authors": "Pino Gonzalez, M.; Lazaro Quintela, M. E.; Oria de Rueda, G. d. V.; Duenas Porto, M.; Alonso Alvarez, I.; Francisco Fernandez, A.; San Miguel Fraile, M. P.; Ortiz Rey, J. A.; Gallardo Gomez, M.; Carracedo Videira, L.; Gallach Garcia, S.; Jantus Lewintre, E.; Martinez Fernandez, M.",
        "category": "genetic and genomic medicine",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_by_nc_nd",
        "institution": "Translational Oncology Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Hospital Alvaro Cunqueiro, Carretera Clara Campoamor, 341, "
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.08.27.26361529:v2",
      "title": "Global Adoption of openEHR Clinical Data Repositories: A Vendor and Community Survey",
      "summary": "The openEHR standard provides an open, vendor-neutral architecture for clinical data repositories (CDRs), yet its real-world deployment has not been systematically documented. We conducted a dual-perspective survey combining a vendor survey of openEHR CDR providers with a community survey of openEHR practitioners. Eleven vendor organisations reported deployments across 22 countries and over 100 institutions and health regions. A complementary community survey (n=29, 17 countries) provided context on regulatory environments, adoption drivers, and barriers. Combined, the surveys cover 28 countries, 26 of them with a reported openEHR CDR deployment. Three findings emerge: openEHR has achieved national-scale presence through two distinct channels. Through vendor-market convergence, openEHR-based systems cover the majority of regional health authorities without a national mandate, including 19 of 21 Swedish regions, 3 of 4 Norwegian health regions, and 16 of 21 Finnish wellbeing services counties. Through national health record adoption, governments have built or procured national systems on openEHR as their technical foundation, including Ireland, Malta, Greece, Jamaica and Slovenia. Across Europe, this constitutes an openEHR-based interoperability infrastructure already in place across multiple EU member states. We identified no country in which openEHR is named in binding national regulation, creating structural fragility and an unrealised opportunity for alignment with the European Health Data Space (EHDS). Second, 61% of deployments serve primary use only, and 12% support both primary and secondary use. Third, lack of openEHR-specific knowledge is the most consistent adoption barrier across all geographies and deployment tiers. Adoption is driven by practitioner need and innovation, not by regulatory mandate.",
      "published_date": "2026-09-06",
      "url": "https://doi.org/10.64898/2026.08.27.26361529",
      "metadata": {
        "doi": "10.64898/2026.08.27.26361529",
        "version": "2",
        "authors": "Kohler, S.; Meyer-Eschenbach, F.; Michelena, X.; Frey, N.; Marschollek, M.; Eils, R.",
        "category": "health informatics",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_by",
        "institution": "Digital Health Center, Berlin Institute of Health at Charite - Universitaetsmedizin Berlin, Berlin, Germany"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.08.05.26359735:v2",
      "title": "Reclassification of Genetic Variants in Patients with Hypertrophic Cardiomyopathy from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)",
      "summary": "Background: Genetic testing is a Class I recommendation for patients with hypertrophic cardiomyopathy (HCM). Variant classification relies on evidence from publicly available case data, evolving classification rules, and gene-disease associations. Thus, as knowledge increases, genetic variant classifications change over time. We evaluated the occurrence and reasons for variant reclassification from a large multi-center international HCM registry (Sarcomeric Human Cardiomyopathy Registry; SHaRe), with the goal to minimize uncertainty for patients and clinicians. Methods: Participants receive clinical care at specialized HCM centres. Baseline classifications were derived from the clinical genetic test report (original or updated) or prior further adjudication by SHaRe geneticists. All variants were then computationally reannotated and reevaluated during 2024-2025. Variants underwent expedited curation if no new evidence was present. The remainder underwent full manual curation using accepted criteria and classified as pathogenic/likely pathogenic (P/LP), variant of uncertain significance (VUS) and benign/likely benign (B/LB). VUS were sub-classified to high, mid or low. Results: Of 12,187 HCM patients, 8,054 (66%) had genetic testing between 1990-2024, and 4,923 (61%) had a variant identified in one of 29 ClinGen-validated HCM genes (1606 unique variants). Expedited curation was performed for 704 (44%) variants and 902 (56%) underwent manual curation. There were 1279 (79%) variants that retained their classification: 148 B/LB, 663 VUS, and 468 P/LP. While 276 (17%) variants (n=557 patients) were reclassified, including 73 upgrades: 61 from VUS to P/LP (199 patients), and 12 from B/LB to VUS. There were 203 downgrades: 108 from P/LP to VUS (196 patients), and 95 from P/LP or VUS to B/LB. VUS were additionally subclassified: 90 VUS-High, 129 VUS-Mid, 115 VUS-Low. Sub-classification of VUS resulted in less uncertainty, with 369 (40.6%) variants reclassified as VUS-Low or B/LB, indicating a very strong probability of not being HCM associated. Conclusions: Clinically meaningful reclassification occurred in 10% of variants identified in HCM probands. Most VUS were unlikely to be causal, and sub-classification has potential to reduce their burden on clinicians and families. Contemporary approaches to classification can minimize uncertainty of genetic results and highlight the need for periodic reevaluation.",
      "published_date": "2026-09-07",
      "url": "https://doi.org/10.64898/2026.08.05.26359735",
      "metadata": {
        "doi": "10.64898/2026.08.05.26359735",
        "version": "2",
        "authors": "Hespe, S.; Powell, G.; Catto, L.; Stewart, N.; Baker, A.; Krishnan, N.; Mitchell, L. A.; Henden, N.; Richardson, E.; Butters, A.; Theotokis, P.; Buchan, R.; McGurk, K. A.; Claggett, B.; Abrams, D.; Ashley, E.; Parikh, V. N.; Day, S. M.; Helms, A. S.; Lampert, R.; Lin, K. Y.; Rossano, J. W.; Zwetsloot, P. P.; Michels, M.; Miller, E. M.; Girolami, F.; Olivotto, I.; Owens, A.; Pereira, A. C.; Ryan, T. D.; Saberi, S.; Russell, M. W.; Stendahl, J. C.; Gray, B.; Argiro, A.; Maurizi, N.; Crotti, L.; Vissing, C. R.; Lakdawala, N. K.; Ho, C. Y.; Ware, J. S.; Ingles, J.",
        "category": "genetic and genomic medicine",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_by",
        "institution": "Garvan Institute of Medical Research, and UNSW Sydney, Sydney, NSW, Australia"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.07.21.26358398:v3",
      "title": "Nucleus basalis of Meynert integrity is associated with cognitive dysfunction in Parkinson's disease independently of locus coeruleus degeneration",
      "summary": "BackgroundDegeneration in the cholinergic nucleus basalis of Meynert (nbM) is thought to contribute to early cognitive deficits in Parkinsons disease (PD). However, it is unknown whether this relationship is confounded by the parallel degeneration of the substantia nigra (SN) and the locus coeruleus (LC), and whether this relationship is unique to PD.\n\nMethodsWe conducted a cross-sectional analysis in 112 PD patients (disease duration <10 years) and 46 controls who underwent standard neuropsychological testing, diffusion-weighted and neuromelanin magnetic resonance imaging. Mean diffusivity (MD) of the nbM and neuromelanin signal of the SN and LC were used as proxy measures of neurodegeneration.\n\nResultsnbM MD did not differ between PD patients and controls ({beta}=0.05, 95% CI [-0.27, 0.37], p=.771), a finding that was replicated using other MRI metrics. Higher nbM MD in PD patients was associated with worse executive function ({beta}=-0.22, 95% CI [-0.39, -0.05], pFDR=.027), controlling for degeneration in the SN and LC. An association with attention did not survive multiple comparisons correction ({beta}=-0.22, 95% CI [-0.41, -0.02], pFDR=.112), and there was no association with memory ({beta}=0.08, 95% CI [-0.15, 0.30], pFDR=.572). When considering both groups jointly, the relationship between increased nbM MD and worse executive function was stronger in PD than controls ({beta}nbM*Group=-0.30, 95% CI [-0.54, -0.06], pFDR=.036).\n\nConclusionOur findings suggest that in early-stage PD, nbM microstructural changes may account for unique variance in executive dysfunction in PD, independent of the effects of LC degeneration, and with a stronger association in PD than controls.\n\nKEY MESSAGESO_ST_ABSWhat is already known on this topicC_ST_ABSAlthough cognitive deficits may stem, at least in part, from degeneration of cholinergic neurons in the nucleus basalis of Meynert (nbM), it is unknown whether this relationship is confounded by the parallel degeneration of the substantia nigra (SN) and the locus coeruleus (LC), and whether this relationship is unique to PD.\n\nWhat this study addsThe novelty of our approach is that we considered the effects of the nbM, SN, and LC jointly rather than in isolation. We found that in early-stage PD, loss of nbM microstructural integrity was associated with executive dysfunction in PD, independent of the association of LC and executive dysfunction.\n\nHow this study might affect research, practice, or policyThese findings have important clinical implications because they suggest that the effects of degeneration in the cholinergic and noradrenergic system are at least partially independent and therefore could be targeted separately for remediating cognitive impairments.",
      "published_date": "2026-09-06",
      "url": "https://doi.org/10.64898/2026.07.21.26358398",
      "metadata": {
        "doi": "10.64898/2026.07.21.26358398",
        "version": "3",
        "authors": "Bailey, A.; St-Onge, E.; Madge, V.; Shafiee, N.; Gagnon, J.-F.; Dagher, A.; Collins, D. L.; Sharp, M.",
        "category": "neurology",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_by_nc_nd",
        "institution": "University of Toronto"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.07.01.26357044:v2",
      "title": "The Association between Marital Status and Suicide Risk Among Patients with Breast Cancer A Population-Based sIPTW Competing Risk Analysis",
      "summary": "Background: Marital status at diagnosis may capture aspects of social support, but it is not a direct measure of support quality. This study examined its association with suicide mortality after breast cancer diagnosis while accounting for competing mortality and exploring variation by county-level income and rural-urban residence. Methods: Adults of both sexes diagnosed with first primary breast cancer in SEER between 2000 and 2022 were studied using a baseline complete-case cohort. Marital status was classified as married/partnered or unmarried/non-partnered. Stabilized inverse probability of treatment weighting (sIPTW) was combined with multivariable Fine-Gray regression, treating non-suicide death as a competing event. Cox, landmark, exploratory subgroup, interaction, and unweighted treatment-adjusted sensitivity analyses were performed. Results: The analytical cohort included 825,047 patients, of whom 40.7% were unmarried/non-partnered. All baseline standardized mean differences were below 0.01 after weighting. During 6,816,981.42 person-years, 506 suicide deaths occurred (7.42 per 100,000 person-years). Unmarried/non-partnered status was associated with higher suicide mortality in the primary Fine-Gray model (sHR 1.34, 95% CI 1.12-1.60) and Cox model (HR 1.45, 95% CI 1.21-1.73). Landmark sHRs at 1, 3, and 5 years were 1.39, 1.46, and 1.34, respectively. The treatment-adjusted sensitivity estimate was 1.26 (95% CI 0.99-1.60; P = 0.064). Income interaction analysis suggested heterogeneity (joint P = 0.042), but the Q4 conditional sHR was imprecise (1.06, 95% CI 0.80-1.39). There was no statistically significant rural-urban interaction (P = 0.488). Conclusions: Unmarried/non-partnered status was associated with higher suicide mortality after breast cancer diagnosis, although the absolute rate was low. The observational design, sensitivity-analysis uncertainty, and exploratory income interaction warrant cautious interpretation and independent validation.",
      "published_date": "2026-09-07",
      "url": "https://doi.org/10.64898/2026.07.01.26357044",
      "metadata": {
        "doi": "10.64898/2026.07.01.26357044",
        "version": "2",
        "authors": "Zou, X.; Shi, J.",
        "category": "oncology",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_no",
        "institution": "Institute of Genetics and Cancer, The University of Edinburgh, Western General Hospital, Edinburgh, UK."
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.04.07.26350286:v2",
      "title": "Challenges in the Computational Reproducibility of Linear Regression Analyses: An Empirical Study",
      "summary": "Background: Reproducibility concerns in health research have grown, as many published results fail to be independently reproduced. Achieving computational reproducibility, where others can replicate the same results using the same methods, requires transparent reporting of statistical tests, models, and software use. While data-sharing initiatives have improved accessibility, the actual usability of shared data for reproducing research findings remains underexplored. Addressing this gap is crucial for advancing open science and ensuring that shared data meaningfully support reproducibility and enable collaboration, thereby strengthening evidence-based policy and practice. Methods: A random sample of 95 PLOS ONE health research papers from 2019 reporting linear regression was assessed for data-sharing practices and computational reproducibility. Data were accessible for 43 papers. From the randomly selected sample, the first 20 papers with available data were assessed for computational reproducibility. Three regression models per paper were reanalysed. Results: Of the 95 papers, 68 reported having data available, but 25 of these lacked the data required to reproduce the linear regression models. Only eight of 20 papers we analysed were computationally reproducible. A major barrier to reproducing the analyses was the great difficulty in matching the variables described in the paper to those in the data. Papers sometimes failed to be reproduced because the methods were not adequately described, including variable adjustments and data exclusions. Conclusion: More than half (60%) of analysed studies were not computationally reproducible, raising concerns about the credibility of the reported results and highlighting the need for greater transparency and rigour in research reporting. When data are made available, authors should provide a corresponding data dictionary with variable labels that match those used in the paper. Analysis code, model specifications, and any supporting materials detailing the steps required to reproduce the results should be deposited in a publicly accessible repository or included as supplementary files. To increase the reproducibility of statistical results, we propose a Model Location and Specification Table (MLast), which tracks where and what analyses were performed. In conjunction with a data dictionary, MLast enables the mapping of analyses, greatly aiding computational reproducibility.",
      "published_date": "2026-09-06",
      "url": "https://doi.org/10.64898/2026.04.07.26350286",
      "metadata": {
        "doi": "10.64898/2026.04.07.26350286",
        "version": "2",
        "authors": "Jones, L. V.; Barnett, A.; Hartel, G.; Vagenas, D.",
        "category": "health systems and quality improvement",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_by_nc",
        "institution": "QUT: Queensland University of Technology"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.04.03.26349172:v2",
      "title": "Maternal health factors driving breastfeeding success: an evidence triangulation framework",
      "summary": "Despite well-established benefits to mothers and children, breastfeeding rates fall short of WHO recommendations world-wide. Breastfeeding is a highly complex behaviour, affected by known system-level barriers and less well-established individual-level factors. We aimed to inform breastfeeding support by identifying maternal and perinatal determinants of breastfeeding outcomes and modifiable pathways linking education to breastfeeding. We used evidence triangulation design from complementary genetic and questionnaire-based analyses across four European cohorts including 72,653 mothers and 317,651 offspring. Five breastfeeding outcomes were assessed: initiation, establishment at 2 months, sustained breastfeeding at 6 months, and exclusive and overall breastfeeding duration. Cohort-specific breastfeeding GWAS were meta-analysed and used in two-sample Mendelian randomization (MR) analyses of 17 maternal and perinatal exposures. MR-based mediation assessed pathways linking educational attainment to breastfeeding, and robustness was evaluated using offspring-genotype adjustment, observational association and MR sensitivity analyses. Genetically predicted higher education, lower body-mass index (BMI), and lower liability to smoking, insomnia and depression were associated with more favorable breastfeeding outcomes. A 1SD (3.4-year) increase in education duration increased initiation odds (OR: 2.32, 95% CI: 1.94,2.77) and prolonged exclusive breastfeeding (beta=0.21SD, 95% CI: 0.17,0.24), whereas higher BMI reduced initiation (OR: 0.77, 95% CI: 0.66,0.90). Smoking, depression and BMI mediated 26%, 14% and 12% of education effect on exclusive breastfeeding, respectively. There was little evidence for effects of blood pressure, cholesterol or perinatal factors. Findings were consistent across sensitivity analyses. These findings highlight that breastfeeding support could be achieved through a more holistic approach to maternal physical and mental health before and during pregnancy, and that targeted strategies would reduce maternal and infant health inequalities.",
      "published_date": "2026-09-07",
      "url": "https://doi.org/10.64898/2026.04.03.26349172",
      "metadata": {
        "doi": "10.64898/2026.04.03.26349172",
        "version": "2",
        "authors": "Arisido, M. W.; Borges, M. C.; Giambartolomei, C.; McBride, N.; Joaquim Hofmeister, R.; Kutalik, Z.; Magnus, M. C.; Zuccolo, L.",
        "category": "epidemiology",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_by",
        "institution": "Health Data Center, Human Technopole"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.64898/2026.03.26.26349455:v5",
      "title": "A Comparative Study in Surgical AI: Potential and Limitations of Data, Compute, and Scaling",
      "summary": "Recent Artificial Intelligence (AI) models have matched or exceeded human experts in several benchmarks of biomedical task performance, but multi-modal benchmarks involving surgery in particular are often missing from prominent medical benchmark suites (specifically, those requiring visual recognition beyond just text question-answering). Since surgery requires coordinating disparate tasks---including multimodal data integration, human interaction, and physical effects---generally-capable AI models could be particularly attractive as collaborative tools if performance could be improved. On the one hand, the canonical approach of scaling architecture size and training data is attractive, especially since there are millions of hours of surgical video data generated per year. On the other hand, preparing surgical data for AI training requires significantly higher levels of professional expertise, and training on that data requires expensive computational resources. These trade-offs paint an uncertain picture of whether and to-what-extent modern AI could aid surgical practice. In this paper, we explore this question through a case study of surgical tool detection using state-of-the-art AI methods available in 2026. We demonstrate that even with multi-billion parameter models and extensive training, current Vision Language Models fall short in the seemingly simple task of tool detection in neurosurgery. Additionally, we show scaling experiments indicating that increasing model size and training time only leads to diminishing improvements in relevant performance metrics. Thus, our experiments suggest that current models could still face significant obstacles in surgical use cases. Moreover, some obstacles cannot simply be ``scaled away'' with additional compute and persist across diverse model architectures, raising the question of whether data and label availability are the only limiting factors. We discuss the main contributors to these constraints and advance potential solutions.",
      "published_date": "2026-09-07",
      "url": "https://doi.org/10.64898/2026.03.26.26349455",
      "metadata": {
        "doi": "10.64898/2026.03.26.26349455",
        "version": "5",
        "authors": "Skobelev, K.; Fithian, E.; Baranovski, Y.; Cook, J.; Angara, S.; Otto, S.; Yi, Z.-F.; Zhu, J.; Mainkar, N.; Masson-Forsythe, M.; Donoho, D. A.; Han, X. Y.",
        "category": "surgery",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_by_nd",
        "institution": "Chicago Booth"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.1101/2025.10.19.25337876:v4",
      "title": "Network subtypes of cortical similarity reveal molecular correlates of normative and compensatory ageing associated with longevity-gene expression",
      "summary": "Background: Ageing is marked by widespread cortical changes, but the molecular underpinning and network-level mechanisms associated with this variability remain poorly understood. Methods: We analysed structural MRI data from 952 adults aged 18--94 using morphometric similarity networks, subtype and stage inference, and cortical transcriptomics. Intranetwork connectivity was examined within the three cortical networks and compared with cortical expression patterns of longevity-associated genes. Results: Based on distinct intra-network morphometric similarity patterns and their associations with longevity genes, two ageing-related subtypes emerged. The normative-ageing subtype (metabolic-immune) showed connectivity profiles consistent with typical age-related decline and was enriched for genes involved in metabolism, insulin signalling, and immune regulation. The compensatory subtype (stress-repair) displayed more preserved intra-network connectivity and was associated with genes linked to stress response, DNA repair, and proteostasis. Although the two subtypes overlapped in oxidative stress and neurodegeneration pathways, they showed divergent molecular signatures associated with different cortical ageing patterns. Conclusion: By integrating network-based morphometry with transcriptomics, we establish a modelling approach that distinguishes normative decline from compensatory adaptation in cortical ageing and provides biologically informed markers of brain ageing.",
      "published_date": "2026-09-07",
      "url": "https://doi.org/10.1101/2025.10.19.25337876",
      "metadata": {
        "doi": "10.1101/2025.10.19.25337876",
        "version": "4",
        "authors": "Batziou, V.; Young, A.; Rittman, T.; Vuksanovic, V.",
        "category": "radiology and imaging",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_by_nc",
        "institution": "Health Data Science, Swansea University"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.1101/2025.05.05.25326993:v2",
      "title": "GLP-1 receptor agonist use is associated with shorter survival in patients with amyotrophic lateral sclerosis and diabetes mellitus",
      "summary": "Background: The glucagon-like-peptide-1 (GLP-1) hormone exerts metabolic effects leading to delayed gastric emptying, decreased appetite, and lower blood glucose levels. GLP-1 receptor agonists (GLP-1RA) are increasingly used to treat diabetes mellitus (DM) and obesity. However, their impact on the progression of amyotrophic lateral sclerosis (ALS) is unknown. Objective: We examined the relationship between GLP-1RA treatment and disease progression among people with ALS and DM. Methods: An electronic health record search was conducted to identify consecutive patients seen at a single institution from 2020 to 2024 with ALS and DM diagnostic codes. All charts were reviewed for demographics, disease history, medication use, and tracheostomy/survival. Patients who did not meet Awaji ALS diagnostic criteria, lacked a documented history of DM, or had insufficient records were excluded. Patients were grouped by GLP-1RA exposure. Tracheostomy-free survival was compared between the GLP-1RA and No-GLP-1RA groups using Kaplan-Meier survival curves, log-rank test and Cox-proportional hazard models adjusted for age, sex, bulbar onset, body mass index (BMI) at diagnosis, and riluzole use. Results: Total 1,310 ALS patients were screened, 136 patients (10%) had comorbid DM. After chart review, 85 patients meeting inclusion and exclusion criteria were included, 15 (18%) of whom were treated with GLP-1RA. Compared to No-GLP-1RA group, GLP-1RA group was younger at symptom onset (59 vs 66 years old, p<0.01), had shorter diagnostic delay (12 months vs 17 months, p=0.04) and higher weight at diagnosis (85kg vs 73kg, p=0.02). Tracheostomy-free survival from symptom onset trended shorter in the GLP-1RA group (median survival 28.7 vs 34.9 months, p=0.08). After adjusting for covariates, the GLP-1RA group was associated with increased mortality compared to the No-GLP-1RA group (hazard ratio 2.5, 95% confidence interval [1.1, 5.3], p=0.02). Conclusions: Treatment with GLP-1RA is associated with shorter tracheostomy-free survival in people with ALS and comorbid DM.",
      "published_date": "2026-09-06",
      "url": "https://doi.org/10.1101/2025.05.05.25326993",
      "metadata": {
        "doi": "10.1101/2025.05.05.25326993",
        "version": "2",
        "authors": "Lee, I.; Hwang, J.; Stolwyk, K.; Harms, M.; Andrews, J.; Shneider, N.",
        "category": "neurology",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_no",
        "institution": "Columbia University Irving Medical Center"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    },
    {
      "source": "medrxiv",
      "source_id": "10.1101/2025.02.08.25321933:v4",
      "title": "Sex and gender differences in OCD: A scoping review and a two subtypes hypothesis",
      "summary": "This scoping review explores sex and gender differences in obsessive-compulsive disorder (OCD) as reported in the literature between 2009 and 2026. A comprehensive PubMed search was conducted without restrictions, using terms related to sex, gender, and OCD. 8,394 articles were screened by two reviewers, with 1,773 assessed at the full-text level. Of these, 1,038 were included: 72 meta-analyses, 19 systematic reviews, 47 narrative reviews, 3 conceptual and integrative reviews, and 897 original reports. Original reports were categorized by focus - symptomology and burden (120), comorbidities (231), epidemiology (255), human genetics (101), altered neurocognitive and neurobiological functioning (74), treatment (86), and animal models (63) - and assessed for quality using CASP checklists. There was abundant research on sex and gender effects in OCD, but limited synthesis. Identified methodological concerns included inconsistent assessments of sex and gender, variability in OCD symptom measurement, failure to account for menstrual cycle effects, and a lack of genome-wide and full-brain imaging studies. Biases in results may arise from not accounting for gender differences in insight, help-seeking behaviors, and comorbidity. We identify critical knowledge gaps and develop hypotheses for future research, incorporating recommendations for precision medicine approaches. Investigating sex and gender differences in OCD can advance equitable mental health care by addressing the specific needs of diverse populations. Appreciating these effects offers a pathway to better understanding the complexity of OCD, fostering targeted interventions and a more nuanced approach to treatment and prevention",
      "published_date": "2026-09-07",
      "url": "https://doi.org/10.1101/2025.02.08.25321933",
      "metadata": {
        "doi": "10.1101/2025.02.08.25321933",
        "version": "4",
        "authors": "Van Zandt, M. A.; Olfson, E.; Stahnke, B.; Taylor, S.; Wise, A.; Williams, C.; Bloch, M. H.; Pittenger, C.; Pushkarskaya, H.",
        "category": "psychiatry and clinical psychology",
        "type": "PUBLISHAHEADOFPRINT",
        "license": "cc_by_nc_nd",
        "institution": "Yale University School of Medicine"
      },
      "fetched_at": "2026-09-09T04:18:05.530Z"
    }
  ],
  "next_cursor": null
}